中文(简体)
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

iris/抗真菌药

链接已保存到剪贴板
14 结果

Iris pattern recognition and alignment

只有注册用户可以翻译文章
登陆注册
BACKGROUND OF THE INVENTION 1. Field of the Invention This invention relates generally to the field of laser vision correction and laser eye surgery, and more specifically to a device, system and methods for alignment of diagnostic and treatment images of the eye for more accurate surgical outcomes

Therapeutic CD47 antibodies

只有注册用户可以翻译文章
登陆注册
SEQUENCE LISTING The present application is being filed along with a sequence listing in electronic format. The sequence listing is provided as a file entitled, "VLX0001-201-US 20131212 SequenceListing_ST25", created on Dec. 11, 2013 which is 90 Kb in size. The information in the electronic format

Therapeutic CD47 antibodies

只有注册用户可以翻译文章
登陆注册
SEQUENCE LISTING The present application is being filed along with a sequence listing in electronic format. The sequence listing is provided as a file entitled, "VLX0001-201-US 20131212 SequenceListing_ST25", created on Dec. 11, 2013 which is 90 Kb in size. The information in the electronic format

Therapeutic CD47 antibodies

只有注册用户可以翻译文章
登陆注册
SEQUENCE LISTING The present application is being filed along with a sequence listing in electronic format. The sequence listing is provided as a file entitled, "VLX0001-201-US 20131212 SequenceListing_ST25", created on Dec. 11, 2013 which is 90 Kb in size. The information in the electronic format

Therapeutic CD47 antibodies

只有注册用户可以翻译文章
登陆注册
The present invention relates to antibodies that bind CD47 and their use in treating conditions and disorders, such as ischemia-reperfusion injury (IRI) and cancers, mediated by this receptor. CD47 is a cell surface receptor comprised of an extracellular IgV set domain, a 5 membrane spanning

Therapeutic CD47 antibodies

只有注册用户可以翻译文章
登陆注册
INCORPORATION OF SEQUENCE LISTING The present application is being filed along with a Sequence Listing in electronic format. The Sequence Listing is provided as a file entitled, "VLX0001-201CIP2 US_SequenceListing", created on Jun. 11, 2015, which is 168,755 bytes in size. The information in the

Therapeutic CD47 antibodies

只有注册用户可以翻译文章
登陆注册
BACKGROUND The present disclosure relates to antibodies that bind CD47, including that of humans and other mammalian species, and their use in treating conditions and disorders, such as ischemia-reperfusion injury (IRI) and cancers, mediated by this receptor. CD47 is a cell surface receptor

Method and apparatus for therapeutic electromagnetic treatment

只有注册用户可以翻译文章
登陆注册
FIELD OF THE INVENTION The present invention relates generally to the art of therapeutic electromagnetic treatment and more specifically to a method and apparatus for utilizing a spatially extended pulsed light source such as a flashlamp (flash tube) for such a treatment or, efficiently focusing

Method and apparatus for therapeutic electromagnetic treatment

只有注册用户可以翻译文章
登陆注册
FIELD OF THE INVENTION The present invention relates generally to the art of therapeutic electromagnetic treatment and more specifically to a method and apparatus for utilizing a spatially extended pulsed light source such as a flashlamp (flash tube) for such a treatment or, efficiently focusing

Polyoma virus JC peptides and proteins in vaccination and diagnostic applications

只有注册用户可以翻译文章
登陆注册
RELATED APPLICATIONS This application is a 35 U.S.C. 371 national stage filing of International Application No. PCT/EP2012/064445, filed on Jul. 23, 2012, which claims priority to European Patent Application No. 11006031.6, filed on Jul. 22, 2011. The contents of the aforementioned applications are

Cyclic compounds

只有注册用户可以翻译文章
登陆注册
TECHNICAL FIELD The present invention relates to novel cyclic compounds having a Toll-like receptor 4 (TLR4) signal inhibitory action useful as preventive and therapeutic drugs of autoimmune disease and/or inflammatory disease or diseases such as chemotherapy-induced peripheral neuropathy (CIPN),

Cyclic compounds

只有注册用户可以翻译文章
登陆注册
TECHNICAL FIELD The present invention relates to novel cyclic compounds having a Toll-like receptor 4 (TLR4) signal inhibitory action useful as preventive and therapeutic drugs of autoimmune disease and/or inflammatory disease or diseases such as chemotherapy-induced peripheral neuropathy (CIPN),

Method for localized staining of an intact corneal tissue surface

只有注册用户可以翻译文章
登陆注册
FIELD OF THE INVENTION The present invention relates to methods for staining tissue surfaces by covalently binding sulfonic acid dyes to deprotonated proteins in tissue. This invention also relates to methods for staining tissue surfaces with black sulfonic acid dye compositions, particularly for

System for providing pulsed light to an optical fiber

只有注册用户可以翻译文章
登陆注册
FIELD OF THE INVENTION The present invention relates generally to the art of therapeutic electromagnetic treatment and more specifically to a method and apparatus for utilizing a spatially extended pulsed light source such as a flashlamp (flash tube) for such a treatment or, efficiently focusing
加入我们的脸书专页

科学支持的最完整的草药数据库

  • 支持55种语言
  • 科学支持的草药疗法
  • 通过图像识别草药
  • 交互式GPS地图-在位置标记草药(即将推出)
  • 阅读与您的搜索相关的科学出版物
  • 通过药效搜索药草
  • 组织您的兴趣并及时了解新闻研究,临床试验和专利

输入症状或疾病,并阅读可能有用的草药,输入草药并查看所使用的疾病和症状。
*所有信息均基于已发表的科学研究

Google Play badgeApp Store badge